Pre‐B acute lymphoblastic leukemia presenting with <i>NPM1</i> and <i>FLT3</i> mutations-Reference-Cited by-同舟云学术

Pre‐B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations

Published:2024-04-03 Issue:10 Volume:99 Page:2018-2022
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Khan Alesia A.¹,James Daniel²,Andresen Vibeke³,Atkey Julie¹,Bradbury Rachel¹,Cargo Catherine¹,Dillon Richard⁴,Gjertsen Bjørn Tore³⁵,Goldstone Antony R.²,Leach Richard¹,Lock Daniel¹,Narayanan Mayanka²,Russell Nigel⁴,Verigou Eleni‐Anna²,Green Simone²,Fielding Adele K.²⁶,Falini Brunangelo⁷^ORCID

Affiliation:

1. Hematological Malignancy Diagnostic Service Leeds Teaching Hospitals Leeds UK

2. Centre for Blood Research Hull University Teaching Hospitals NHS Trust Hull UK

3. Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science University of Bergen Bergen Norway

4. Department of Medical and Molecular Genetics Guy's and King's Hospitals London UK

5. Department of Medicine, Hematology Section Haukeland University Hospital Bergen Norway

6. Centre for Blood research University of York York UK

7. Institute of Hematology and Center for Haemato‐Oncological research (CREO) University of Perugia and Santa Maria della Misericordia Hospital Perugia Italy

Funder

H2020 European Research Council

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27301

Reference14 articles.

1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

2. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

3. NPM1-mutated acute myeloid leukemia: from bench to bedside

4. Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

5. The NPM1 mutant defines AML irrespective of blast count